Arteris (NASDAQ:AIP) Stock Price Target Cut by Jefferies Financial Group

Arteris (NASDAQ:AIP) had its price target cut by equities research analysts at Jefferies Financial Group from $50.00 to $40.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm presently has a “buy” rating on the stock. Jefferies Financial Group‘s price objective indicates a potential upside of 124.72% from the stock’s previous close.

A number of other equities research analysts also recently weighed in on AIP. Rosenblatt Securities reiterated a “buy” rating and issued a $38.00 price target on shares of Arteris in a report on Friday, August 7th. TD Cowen decreased their price objective on shares of Arteris from $40.00 to $25.00 and set a “buy” rating for the company in a report on Monday, October 19th. Oppenheimer initiated coverage on shares of Arteris in a research note on Thursday, July 16th. They set an “outperform” rating and a $40.00 target price for the company. Weiss Ratings raised shares of Arteris from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, August 21st. Finally, Roth Capital began coverage on shares of Arteris in a report on Tuesday, August 4th. They set a “buy” rating and a $40.00 target price on the stock. Six analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Arteris presently has an average rating of “Moderate Buy” and an average price target of $35.86.

Arteris Stock Up 11.7%

Shares of NASDAQ AIP traded up $1.87 on Friday, hitting $17.80. The company had a trading volume of 1,430,681 shares, compared to its average volume of 720,131. The business has a 50 day moving average of $21.51 and a two-hundred day moving average of $24.94. The firm has a market capitalization of $874.91 million, a P/E ratio of -20.46 and a beta of 1.93. Arteris has a 12-month low of $12.06 and a 12-month high of $50.26. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.03.

Arteris (NASDAQ:AIP) last released its quarterly earnings results on Thursday, November 5th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.02. Arteris had a negative net margin of 46.70% and a negative return on equity of 295.96%. The firm had revenue of $25.77 million for the quarter, compared to the consensus estimate of $24.57 million. As a group, equities research analysts forecast that Arteris will post -0.68 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Arteris news, VP Paul Alpern sold 6,003 shares of the firm’s stock in a transaction on Monday, October 5th. The stock was sold at an average price of $24.24, for a total value of $145,512.72. Following the sale, the vice president directly owned 61,082 shares in the company, valued at approximately $1,480,627.68. This trade represents a 8.95% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO K Janac sold 11,452 shares of the business’s stock in a transaction on Monday, October 5th. The shares were sold at an average price of $24.27, for a total transaction of $277,940.04. Following the transaction, the chief executive officer directly owned 154,337 shares of the company’s stock, valued at approximately $3,745,758.99. This trade represents a 6.91% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 478,631 shares of company stock valued at $10,823,565 over the last three months. Corporate insiders own 23.30% of the company’s stock.

Institutional Trading of Arteris

Hedge funds have recently bought and sold shares of the company. Versant Capital Management Inc boosted its stake in Arteris by 33.7% during the 2nd quarter. Versant Capital Management Inc now owns 1,150 shares of the company’s stock valued at $56,000 after purchasing an additional 290 shares during the period. AlphaCore Capital LLC increased its stake in shares of Arteris by 7.5% in the third quarter. AlphaCore Capital LLC now owns 10,362 shares of the company’s stock valued at $245,000 after purchasing an additional 720 shares during the period. Farther Finance Advisors LLC increased its stake in shares of Arteris by 106.0% in the third quarter. Farther Finance Advisors LLC now owns 1,730 shares of the company’s stock valued at $41,000 after purchasing an additional 890 shares during the period. Sterling Capital Management LLC increased its stake in shares of Arteris by 612.5% in the third quarter. Sterling Capital Management LLC now owns 1,197 shares of the company’s stock valued at $28,000 after purchasing an additional 1,029 shares during the period. Finally, Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of Arteris during the second quarter valued at approximately $53,000. 64.36% of the stock is currently owned by institutional investors.

More Arteris News

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Arteris reported Q3 revenue of $25.8 million, above the roughly $24.6 million consensus estimate. Its loss of $0.02 per share was narrower than analysts expected and improved from a $0.09 loss a year earlier. Arteris Q3 results and guidance
• Positive Sentiment: The company forecast Q4 revenue of $25.7 million to $26.7 million and FY2026 revenue of $98.5 million to $99.5 million. It also set a $103 million to $107 million target for annual contract value plus royalties, offering investors visibility into expected business activity. Arteris FY2026 forecast
• Positive Sentiment: Arteris surpassed 1,000 customer chip-design starts. The company says AI accounted for about half of its recent projects, pointing to potential demand from a fast-growing market. Arteris surpasses 1,000 customer design starts
• Negative Sentiment: Despite the improvement and estimate beat, Arteris remains loss-making, so investors may continue to watch its path toward profitability. Arteris Q3 loss and revenue results

About Arteris

Arteris, Inc is a semiconductor intellectual property (IP) company that provides technology used to design and integrate complex systems-on-chip (SoCs). Its products help semiconductor and system developers connect, manage and verify the various processing, memory and specialized functional components incorporated into modern chips.

The company’s portfolio includes network-on-chip (NoC) interconnect and semiconductor IP solutions, including its FlexNoC interconnect technology, Ncore cache-coherent interconnect IP and CodaCache products.